IL152484A0 - Method for treating cancer, visualizing cell structures, and isolating organelles using organelle crystallizing agents - Google Patents

Method for treating cancer, visualizing cell structures, and isolating organelles using organelle crystallizing agents

Info

Publication number
IL152484A0
IL152484A0 IL15248401A IL15248401A IL152484A0 IL 152484 A0 IL152484 A0 IL 152484A0 IL 15248401 A IL15248401 A IL 15248401A IL 15248401 A IL15248401 A IL 15248401A IL 152484 A0 IL152484 A0 IL 152484A0
Authority
IL
Israel
Prior art keywords
cocid
organelle
agents
treating cancer
cellular
Prior art date
Application number
IL15248401A
Other languages
English (en)
Original Assignee
Kong Qingzhong
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CN 00111092 external-priority patent/CN1275404A/zh
Priority claimed from US09/663,559 external-priority patent/US6376525B1/en
Priority claimed from US09/687,342 external-priority patent/US6368818B1/en
Priority claimed from CN 00129316 external-priority patent/CN1112447C/zh
Application filed by Kong Qingzhong filed Critical Kong Qingzhong
Publication of IL152484A0 publication Critical patent/IL152484A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
IL15248401A 2000-04-29 2001-04-27 Method for treating cancer, visualizing cell structures, and isolating organelles using organelle crystallizing agents IL152484A0 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN 00111092 CN1275404A (zh) 2000-04-29 2000-04-29 抗癌药物组合物
US09/663,559 US6376525B1 (en) 2000-09-15 2000-09-15 Method and composition for treating cancer using cellular organelle crystallizing agents
US09/687,342 US6368818B1 (en) 2000-10-12 2000-10-12 Methods and compositions for the visualization of cellular organelles using tetrazolium salts
CN 00129316 CN1112447C (zh) 2000-11-13 2000-11-13 一种细胞结构的检测方法
PCT/US2001/013730 WO2001082780A2 (en) 2000-04-29 2001-04-27 Method for treating cancer, visualizing cell structures, and isolating organelles using organelle crystallizing agents

Publications (1)

Publication Number Publication Date
IL152484A0 true IL152484A0 (en) 2003-05-29

Family

ID=27429887

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15248401A IL152484A0 (en) 2000-04-29 2001-04-27 Method for treating cancer, visualizing cell structures, and isolating organelles using organelle crystallizing agents
IL152484A IL152484A (en) 2000-04-29 2002-10-24 Salts of tetrasolium derivatives as constituents for organs and skeletons of cells and preparations containing them for killing tumor cells

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL152484A IL152484A (en) 2000-04-29 2002-10-24 Salts of tetrasolium derivatives as constituents for organs and skeletons of cells and preparations containing them for killing tumor cells

Country Status (7)

Country Link
EP (1) EP1294922B1 (xx)
AT (1) ATE464046T1 (xx)
AU (2) AU2001257383B2 (xx)
CA (1) CA2407112C (xx)
DE (1) DE60141829D1 (xx)
IL (2) IL152484A0 (xx)
WO (1) WO2001082780A2 (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2688565A1 (en) 2011-03-23 2014-01-29 Semorex Technologies Ltd. Treatment of proliferative disorders with a chemiluminescent agent

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5726009A (en) * 1989-03-20 1998-03-10 Anticancer, Inc. Native-state method and system for determining viability and proliferative capacity of tissues in vitro

Also Published As

Publication number Publication date
DE60141829D1 (de) 2010-05-27
CA2407112C (en) 2010-02-09
EP1294922B1 (en) 2010-04-14
ATE464046T1 (de) 2010-04-15
CA2407112A1 (en) 2001-11-08
WO2001082780A3 (en) 2002-01-24
AU2001257383B2 (en) 2006-07-06
IL152484A (en) 2009-06-15
AU5738301A (en) 2001-11-12
EP1294922A2 (en) 2003-03-26
WO2001082780A2 (en) 2001-11-08
EP1294922A4 (en) 2007-09-19

Similar Documents

Publication Publication Date Title
YU84603A (sh) Novi inhibitori tirozin kinaze
PL367682A1 (en) Dolastatin 10 derivatives
TR200002191T2 (tr) Potasyum kanal önleyicileri
TR200001279T2 (tr) Poli (ADP-riboz) polimeraz (&#34;PARP&#34;) inhibitörleri, nevral ve kardiyovasküler doku hasarının tedavisi için yöntemler ve farmasötik bileşimler.
BR0212042A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, e, uso de um composto
TR200201505T2 (tr) Terapötik maddeler olarak pirazolopirimidinler
IL229136A (en) Process for making mek inhibitors
DK0853083T3 (da) Pyridylfuran- og piridylthiophenforbindelser og farmaceutisk anvendelse deraf
MX9803792A (es) Inhibidor de proteina cinasa c.
WO2001044247A3 (en) Agents and methods for the treatment of proliferative diseases
WO2003106381A3 (en) ADAM 10 HUMAN INHIBITORS
BR0010938A (pt) Derivados da 13-metil eritromicina
EP1171428A4 (en) FAB I INHIBITORS
TR200401316T4 (tr) Proliferatif hastalıkları tedavi etmek için yöntemler ve bileşikler
HK1066007A1 (en) Cross-linked glycopeptide-cephalosporin antibiotics
AU2003231833A1 (en) Cross-linked glycopeptide-cephalosporin antibiotics
MXPA04008303A (es) Inhibidores de la farnesil proteina transferasa como agentes antitumorales.
TW200510384A (en) Novel farnesyl protein transferase inhibitors as antitumor agents
EP1109560A4 (en) COMPOUNDS USEFUL AS AICARFT INHIBITORS
AU2002364953A1 (en) Topoisomerase poison agents
WO2001030331A3 (en) Therapeutic compositions including protein kinase c inhibitors
MXPA04005809A (es) Inhibidores de proteinas quinasas.
EP1019047A4 (en) ANTITHROMBOTIC AGENTS
DK1549329T3 (da) Ekstrakt med antitumoraktivitet og anti-giftaktivitet
AU5738301A (en) Method for treating cancer, visualizing cell structures, and isolating organelles using organelle crystallizing agents